Beyond Split vs. Full-Thickness Graft: Why Traditional Skin Grafts Fall Short in Chronic Wounds
How graft design, donor sites, and patient factors shape the race for graft survival
By Ned Swanson, MD, President & Chief Medical Officer, PolarityBio
Why Graft Type Matters in the Race
Once a skin graft is placed, it enters a race:
Ischemic injury pushes the graft toward failure
Revascularization pushes it toward survival
But the odds of winning that race are set before the graft ever touches the wound—by graft thickness, donor-site biology, procedural requirements, and patient factors.
Nowhere is this more apparent than in patients with chronic wounds and diabetic foot ulcers (DFUs).
Split-Thickness Skin Grafts (STSGs)
What They Include
Epidermis
A small portion of the dermis (without the regenerative appendages)
How STSGs Affect the Race
Advantages — Buying Time Early
Lower metabolic demand
Shorter diffusion distance for oxygen and nutrients
Less reliance on immediate robust perfusion
Higher initial take rates in compromised wound beds
Race framing:
STSGs tolerate ischemia longer, giving angiogenesis more time to catch up.
Donor Site Requirements, Morbidity & Procedural Considerations (STSG)
Donor site characteristics:
Harvested using a powered dermatome
Typically taken from thigh, buttock, or calf
Can generate large surface-area grafts
Anesthesia requirements:
STSG harvesting is most often performed in the operating room
Commonly requires general anesthesia due to:
Pain associated with dermatome harvesting
Need for precise, controlled graft thickness
Size of donor area
DFU-specific implication:
Many patients with DFUs have significant comorbidities—cardiovascular disease, renal disease, pulmonary disease—that make general anesthesia higher risk, reducing suitability for STSGs despite their biological advantages.
Donor Site Healing & Morbidity (STSG)
Donor site healing:
Heals predictably by secondary intention
Re-epithelialization occurs from:
Residual dermal structures
Hair follicles
Sweat glands
Key biological insight:
The reliable healing of large STSG donor sites powerfully demonstrates the regenerative potential of the dermis.
Donor site morbidity:
Pain
Exudate
Pigmentary change
Scarring
Rare infection
Important contrast:
STSG donor sites almost always heal—highlighting the innate regenerative potential of the dermis.
Expansion Potential (STSG)
STSGs can be meshed and expanded
Allows coverage of large wounds
Trade-offs include:
Slower epithelialization
Fragile interstices
Reduced mechanical durability
Race implication:
Expansion increases coverage but weakens mechanical resilience.
Typical Uses of STSGs
Most commonly used for:
Acute traumatic wounds
Burns
Large, well-vascularized wound beds
Donor sites of large flaps
DFU reality:
If STSGs manage to win the early biological race to survive, they can still be at risk for losing the long-term mechanical battle once weight-bearing resumes. In addition, the OR demands of STSGs may make them less suitable for patients with DFUs that have co-morbidities putting them at risk if less invasive options exist.
Full-Thickness Skin Grafts (FTSGs)
What They Include
Epidermis
Entire dermis
How FTSGs Affect the Race
Advantages — Stronger End State
Greater tensile strength
Improved resistance to shear
Less contraction
Better durability
Better function
Better aesthetic matching
Race framing:
FTSGs offer a stronger finish—if they survive long enough to reach it.
Donor Site Requirements & Morbidity (FTSG)
Donor site characteristics:
Requires primary closure
Limited by skin laxity
Typically harvested from:
Groin
Postauricular region
Supraclavicular area
Donor site morbidity:
Linear scar
Risk of wound dehiscence
Clinical implication:
Donor-site limitations often restrict FTSG size and feasibility.
Expansion Potential (FTSG)
Cannot be meshed or meaningfully expanded
Size limited by donor-site closure
Race implication:
FTSGs demand excellent recipient-site biology and can even struggle in healthy, well-vascularized recipient sites. Given the high recipient-site demands, they are increasingly challenging in chronic wounds with poor vascularity.
Typical Uses of FTSGs
Most commonly used for:
Small, well-vascularized defects
Areas requiring durability and minimal contraction
Facial and hand reconstruction
DFU reality:
FTSGs often lose the race early in plantar DFUs due to inadequate perfusion, prolonged inflammation, and high shear forces.
The STSG Donor Site vs the Chronic DFU: A Critical Contrast
Key comparison:
STSG donor sites regenerate reliably
Chronic DFUs cannot by definition
This contrast underscores a central truth:
Skin has extraordinary regenerative capacity—when dermal biology, perfusion, and signaling are intact.
The DFU Dilemma: Survival vs Durability vs Patient Risk
In plantar DFUs:
STSGs may survive ischemia but fail mechanically and require OR-level care
FTSGs may offer durability but fail biologically
Many patients cannot safely undergo general anesthesia
Clinical takeaway:
The “right” graft biologically may be impractical procedurally—or unsafe medically.
Looking Forward: Beyond Traditional Grafting
Traditional skin grafts assume:
A wound bed capable of angiogenesis
A transient inflammatory phase
Mechanical stability
Patients able to tolerate operative intervention
Chronic DFUs often violate all these assumptions.
Rather than asking a graft to win the race faster, emerging approaches aim to change the rules of the race entirely:
Minimize reliance on immediate perfusion
Deliver multiple native skin cell populations
Support angiogenesis rather than wait for it
Regenerate skin architecture
Reduce procedural and anesthesia burden
Final Thought
Skin graft success isn’t just about technique; it’s about biology, mechanics, and patient risk.
When we understand grafting as a race between ischemia and revascularization, constrained by donor-site biology and procedural realities, the limitations of traditional grafts in DFUs become clear, and the rationale for new approaches comes into focus.
